| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/17/2011 | US20110039338 Method of efficiently establishing induced pluripotent stem cells |
| 02/17/2011 | US20110039331 Tag peptide and use thereof |
| 02/17/2011 | US20110039313 Method for the fermentative production of cadaverine |
| 02/17/2011 | US20110039310 Novel gene sms 37 |
| 02/17/2011 | US20110039308 Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
| 02/17/2011 | US20110039301 Polypeptides Having Organophosphorous Hydrolase Activity and Polynucleotides Encoding Same |
| 02/17/2011 | US20110039279 Methods and compositions for diagnosing breast cancer |
| 02/17/2011 | US20110039266 Flowcell systems for single molecule detection |
| 02/17/2011 | US20110039263 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt2 polypeptides and homologs thereof |
| 02/17/2011 | US20110039262 Methods for detecting virulent plasmodium, for evaluating plasmodium virulence, and for screening new drugs employing the 3'utr of plasmodium sub2 and the plasmodium sub2 serine protease |
| 02/17/2011 | US20110039257 Permuted and nonpermuted luciferase biosensors |
| 02/17/2011 | US20110038971 Method for the Production of Human Recombinant Lysosomal Enzymes in a Cereal Endosperm |
| 02/17/2011 | US20110038923 Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression |
| 02/17/2011 | US20110038922 Compounds for treating or preventing amine oxidase related diseases or disorders |
| 02/17/2011 | US20110038920 Wound healing compositions and treatments |
| 02/17/2011 | US20110038912 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038886 N-Linked Glycosylation Alteration in E0 and E2 Glycoprotein of Classical Swine Fever Virus and Novel Classical Swine Fever Virus Vaccine |
| 02/17/2011 | US20110038874 Anti-vegfr monoclonal antibody, method of making and uses thereof |
| 02/17/2011 | US20110038873 Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (tlx) |
| 02/17/2011 | US20110038869 Monoclonal antibodies against cd32b |
| 02/17/2011 | US20110038868 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/17/2011 | US20110038863 Methods and compositions for improving recombinant protein production |
| 02/17/2011 | US20110038854 Strategy for homo- or hetero-dimerization of various proteins in solution and in cell |
| 02/17/2011 | US20110038853 Use of Kif13A and AP-1 Inhibitors for Inhibiting Melanogenesis |
| 02/17/2011 | US20110038849 Inhibitory polynucleotide compositions and methods for treating cancer |
| 02/17/2011 | US20110038843 Tumor Growth Inhibition Via Conditioning of Tumor Microenvironment |
| 02/17/2011 | US20110038834 Novel avian cytokines and genetic sequences encoding same |
| 02/17/2011 | US20110036146 In-Situ Detection and Analysis of Methane in Coal Bed Methane Formations with Spectrometers |
| 02/17/2011 | CA2776757A1 Positive and negative selectable markers for use in thermophilic organisms |
| 02/17/2011 | CA2771299A1 Multi-transgenic pigs for diabetes treatment |
| 02/17/2011 | CA2771022A1 Photochemical internalization method |
| 02/17/2011 | CA2771021A1 Photosensitizing compositions |
| 02/17/2011 | CA2770842A1 Cytosolic isobutanol pathway localization for the production of isobutanol |
| 02/17/2011 | CA2770825A1 Transgenic animal for production of antibodies having minimal cdrs |
| 02/17/2011 | CA2770774A1 Aromatic prenyltransferase from cannabis |
| 02/17/2011 | CA2770737A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use |
| 02/17/2011 | CA2770716A1 Methods, primers, probes and kits useful for the detection of braf mutations |
| 02/17/2011 | CA2770678A1 Methods of monitoring endoplasmic reticulum (er) stress response |
| 02/17/2011 | CA2770605A1 Fermentation process |
| 02/17/2011 | CA2770557A1 Vector comprising mannose promoter and mannose promoter |
| 02/17/2011 | CA2770550A1 Stress tolerant plants |
| 02/17/2011 | CA2770312A1 Organisms homozygous for targeted modification |
| 02/17/2011 | CA2770240A1 Peptide libraries |
| 02/17/2011 | CA2770104A1 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq) |
| 02/17/2011 | CA2769183A1 Methods for producilng a plant with enhanced vigor |
| 02/17/2011 | CA2769182A1 Methods for producing a plant with enhanced vigor |
| 02/17/2011 | CA2767844A1 Transformation of dicotyledonous plants by an isolated shoot apex meristem method |
| 02/16/2011 | EP2284543A2 System and method of aspirating and dispensing reagent |
| 02/16/2011 | EP2284281A1 REAGENT COMPRISING PRIMER FOR DETECTION OF mRNA FOR CYTOKERATIN-7 |
| 02/16/2011 | EP2284274A1 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines |
| 02/16/2011 | EP2284273A1 Vector comprising mannose promoter and mannose promoter |
| 02/16/2011 | EP2284272A1 Mannanases |
| 02/16/2011 | EP2284271A2 Mutant luciferase |
| 02/16/2011 | EP2284270A2 Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains |
| 02/16/2011 | EP2284269A2 Antisense design |
| 02/16/2011 | EP2284268A2 Conserved HBV and HCV sequences useful for gene silencing |
| 02/16/2011 | EP2284267A2 Modulation of diacylglycerol acyltransferase 2 expression |
| 02/16/2011 | EP2284266A2 Functional and hyperfunctional sirna |
| 02/16/2011 | EP2284265A1 Methods and compositions involving miRNA and miRNA inhibitor molecules |
| 02/16/2011 | EP2284264A1 Induction of exon skipping in eukaryotic cells |
| 02/16/2011 | EP2284263A2 Primer and probe for use in detection of mycobacterium kansasii and method for detection of mycobacterium kansasii using the same |
| 02/16/2011 | EP2284262A1 Primer and probe for detection of mycobacterium intracellulare, and method for detection of mycobacterium intracellulare using the primer or the probe |
| 02/16/2011 | EP2284261A1 Method for production of polyester copolymer using genetically modified microorganism |
| 02/16/2011 | EP2284259A2 Protease variants |
| 02/16/2011 | EP2284195A1 Fusion proteins useful for detecting analytes |
| 02/16/2011 | EP2284194A1 Antibodies directed to angiopoietin-2 and uses thereof |
| 02/16/2011 | EP2284192A2 Camelidae antibodies for sublingual administration |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2284186A1 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
| 02/16/2011 | EP2283870A1 Oligonucleotides inhibiting cellular migration |
| 02/16/2011 | EP2283867A2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates |
| 02/16/2011 | EP2283866A2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates |
| 02/16/2011 | EP2283859A2 Pantropic canine coronavirus |
| 02/16/2011 | EP2283858A2 West Nile Vaccine |
| 02/16/2011 | EP2283855A2 Polypeptides et polynucleotides de phorphorymonas gingivalis |
| 02/16/2011 | EP2283854A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283853A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283852A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283846A1 miRNA compounds for treatment of prostate carcinoma |
| 02/16/2011 | EP2283810A1 Orally administered bacteria as vehicles for systemic delivery of agents |
| 02/16/2011 | EP2283721A2 Genetically engineered duckweed |
| 02/16/2011 | EP2283162A2 Methods and devices based upon a novel form of nucleic acid duplex on a surface |
| 02/16/2011 | EP2283155A2 Preterm delivery diagnostic assay |
| 02/16/2011 | EP2283139A2 Compositions and methods of using rna interference for the control of nematodes |
| 02/16/2011 | EP2283138A1 Production of ospa for lyme disease control |
| 02/16/2011 | EP2283137A1 Recombinant cells and methods for hydroxylating fatty acids |
| 02/16/2011 | EP2283136A2 New chimeric alpha-amylase variants |
| 02/16/2011 | EP2283135A1 Deletion mutants for the production of isobutanol |
| 02/16/2011 | EP2283134A2 Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means |
| 02/16/2011 | EP2283133A2 Compositions and use of epas1 inhibitors |
| 02/16/2011 | EP2283132A2 Selective 5' ligation tagging of rna |
| 02/16/2011 | EP2283131A2 Highly pure plasmid dna preparations and processes for preparing the same |
| 02/16/2011 | EP2283129A1 Proline-specific protease from penicillium chrysogenum |
| 02/16/2011 | EP2283125A1 Drought tolerant plants and related constructs and methods involving genes encoding protein tyrosine phosphatases |
| 02/16/2011 | EP2283122A1 Linezolid resistance mutations in gram-positive bacteria |
| 02/16/2011 | EP2283121A2 Methods and compositions for producing hydrocarbons |
| 02/16/2011 | EP2283120A1 Method for producing recombinant proteins with a constant content of pco2 in the medium |
| 02/16/2011 | EP2283111A2 Improved strains of zymomonas mobilis for fermentation of biomass |
| 02/16/2011 | EP2283038A1 Compositions and methods for expressing in-frame multimeric proteins |